Publications:
- Mayr FB, Yende S, Linde-Zwirble WT, Peck-Palmer OM, Barnato AE, Weissfeld LA, Angus DC. Infection Rate and Acute Organ Dysfunction Risk as Explanations for Racial Differences in Severe Sepsis. JAMA. 2010; 303:2495-2503.
- Mayr FB, Knoebl P, Jilma B, Siller-Matula J, Wagner P, Schaub RG, Gilbert JC, Jilma-Stohlawetz P. The Aptamer ARC1779 blocks VWF dependent platelet function in patients with thrombotic thrombocytopenic purpura (TTP) ex vivo. Transfusion 2010;50:1079-1087.
- Mayr FB, Yende S, D'Angelo G, Kellum JA, Weissfeld L, Yealy D, Barnato AE, Reade MC, Milbrandt EB, Angus DC. Do hospitals provide different quality of care to blacks for pneumonia? Crit Care Med 2010;38:759-65.
- Spiel AO, Mayr FB, Ladani N, Wagner PG, Schaub RG, Gilbert JC, Jilma B. The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction. Platelets 2009;20:334-40.
- Mayr FB, Spiel AO, Leitner JM, Firbas C, Schnee J, Hilbert J, Derendorf W, Jilma B. Influence of the Duffy antigen on pharmacokinetics and pharmacodynamics of monocyte chemoattractant protein (MCP-1) in humans. Int J Immunopathol Pharmacol 2009; 22(3):615-25.
- Spiel AO, Kliegel A, Janata A, Uray T, Mayr FB, Laggner AN, Jilma B, Sterz F. Hemostasis in Cardiac Arrest Patients Treated with Mild Hypothermia Initiated by Cold Fluids. Resuscitation 2009;80:762-5.
- Mayr FB, Spiel AO, Leitner JM, Firbas C, Jilma-Stohlawetz P, Jen-Yeah C, Key NS, Jilma B. Racial Differences in endotoxin induced tissue factor-triggered coagulation; J Thromb Haemost 2009; 7:634-40.
- Spiel AO, Frossard M, Mayr FB, Kliegel A, Janata A, Uray T, Wandaller C, Sterz F, Jilma B. Pronounced platelet hyperfunction in patients with cardiac arrest achieving restoration of spontaneous circulation; Crit Care Med 2009; 37:975-9.
- Reade MC, Yende S, D'Angelo G, Kong L, Kellum JA, Milbrandt EB, Dooley C, Mayr FB, Barnato AE, Weissfeld L, Angus DC. Differences in immune response may explain lower survival among older men with pneumonia. Crit Care Med 2009; 37:1655-62.
- Leitner JM, Mayr FB, Spiel AO, Firbas C, Savulsky C, Mis R, Corrado ME, Jilma B. The pharmacokinetics and pharmacodynamics of a new sustained-release leuprolide acetate depot compared to market references. Int J Clin Pharmacol Ther 2008; 46(8):407-14.
- Spiel AO, Mayr FB, Leitner JM, Firbas C, Sieghart W, Jilma B. Simvastatin and rosuvastatin mobilize Endothelial Progenitor Cells but do not prevent their acute decrease during systemic inflammation. Thromb Res 2008;123(1):108-13.
- Mayr FB, Spiel AO, Leitner JM, Firbas C, Kliegel T, Jilma-Stohlawetz P, Derendorf H, Jilma B. The Duffy Antigen modifies the Inflammatory Response in Human Endotoxemia; Crit Care Med 2008; 36(1):159-65.
- Mayr FB, Firbas C, Leitner JM, Spiel AO, Reiter R, Jilma B. Effects of the pan-selectin antagonist Bimosiamose (TBC1269) in experimental human endotoxemia. Shock 2008; 29(4):475-82.
- Mayr FB, Spiel AO, Leitner JM, Firbas C, Sieghart W, Jilma B. Effects of Low Dose Endotoxemia on Endothelial Progenitor Cells in Humans. Atherosclerosis 2007; 195(1):e202-6.
- Leitner JM, Jilma B, Mayr FB, Cardona F, Spiel AO, Firbas C, Rathgen K, Stähle H, Schühly U, Graefe-Mody EU. Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin induced coagulation. Clin Pharmacol Ther 2007; 81(6):858-66.
- Leitner JM, Mayr FB, Firbas C, Spiel A, Steinlechner B, Novellini R, Jilma B. Reparixin, a specific interleukin-8 inhibitor, has no effects on inflammation during endotoxemia. Int J Immunopathol Pharmacol 2007; 20(1):25-36.
- Mayr FB, Spiel AO, Leitner JM, Firbas C, Kliegel T, Jilma B. Ethnic differences in plasma levels of
- Interleukin-8 and granulocyte colony stimulating factor levels (G-CSF). Transl Res. 2007; 149:10-14.
- Mayr FB, Jilma B. Coagulation Interventions in Experimental Human Endotoxemia. Transl Res. 2006; 148: 263-71.
- Mayr FB, Jilma B. Current Developments in Anti-Platelet Therapy. Wien Med Wochenschr 2006. 156: 472-80.
- Boos CJ, Mayr FB, Lip GY, Jilma B. Endotoxemia enhances circulating endothelial cells in humans. J Thromb Haemost 2006; 4: 2547-52.
- Spiel AO, Mayr FB, Firbas C, Quehenberger P, Jilma B. Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans. J Thromb Haemost 2006; 4: 411-16.
- Leitner JM, Firbas C, Mayr FB, Reiter RA, Steinlechner B, Jilma B. Recombinant human antithrombin inhibits thrombin formation and interleukin-6 release in human endotoxemia. Clin Pharmacol Ther 2006; 79: 23-34.
- Spiel AO, Firbas C, Mayr FB, Leitner JM, Schmidt B, Knobl P, Varadi K, Jilma B. The effects of supranormal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia. Thromb Haemost 2005; 94: 1148-55.
- Mayr FB, Spiel A, Leitner JM, Marsik C, Gehrmann P, Ullrich R, Wagner O, Jilma B. Effects of carbon monoxide inhalation during experimental endotoxemia in humans. Am. J. Respir. Crit. Care Med. 2005; 15; 171:354-60.
- Marsik C, Mayr F, Cardona F, Schaller G, Wagner OF, Jilma B. Endotoxin down-modulates P-selectin glycoprotein ligand-1 (PSGL-1, CD162) on neutrophils in humans. J Clin Immunol 2004; 24:62-5.
- Endler G, Marsik C, Joukhadar C, Marculescu R, Mayr F, Mannhalter C, Wagner OF, Jilma B. The Interleukin 6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 levels in experimental endotoxemia in man. Clin Chem 2004; 50:195-200.
- Marsik C, Halama T, Cardona F, Wlassits W, Mayr F, Pleiner J, Jilma B. Regulation of Fas (APO-1, CD95) and Fas Ligand expression in leukocytes during systemic inflammation in humans. Shock 2003; 20:493-6.
- Reiter RA, Derhaschnig U, Spiel A, Keen P, Cardona F, Mayr F, Jilma B. Regulation of protease-activated receptor 1 (PAR1) on platelets and responsiveness to thrombin receptor activating peptide (TRAP) during systemic inflammation in humans. Thromb Haemost 2003; 90:898-903.
- Reiter RA, Mayr F, Blazicek H, Galehr E, Jilma-Stohlawetz P, Domanovits H, Jilma B. Desmopressin antagonizes the in vitro platelet dysfunction induced by GP IIb/IIIa inhibitors and aspirin. Blood 2003; 102:4594-9.
- Marsik C, Mayr F, Cardona F, Derhaschnig U, Wagner OF, Jilma B. Endotoxaemia modulates Toll-like receptors on leukocytes in humans. Br J Haematol 2003; 121:653-6.
- Jilma B, Marsik C, Mayr F, Graninger MT, Taylor FB, Jr., Ribel MC, Erhardtsen E, Handler S, Eichler HG. Pharmacodynamics of active site inhibited factor VIIa (ASIS, FFR-rFVIIa) in endotoxin induced coagulation in humans. Clin Pharmacol Ther 2002; 72:403-10.
- Yende S, D'Angelo G, Mayr FB, Kellum JA, Kaynar AM, Kaikobad I, Angus DC. Persistent prothrombotic state at hospital discharge after pneumonia increases risk of cardiovascular deaths. Circulation; submitted.
- Spiel AO, Mayr FB. NO-synthase inhibition in sepsis. Thromb Haemost. 2006; 95:591-2.
- Mayr FB, Bilban M, Jilma B. "Low-level" carbon monoxide administration may carry risk. Am J Respir Crit Care Med. 2005; 172:784-5.
- Mayr FB, Yende S, Angus DC. Racial disparities in infection and sepsis - does biology matter? In: Vincent J-L (ed), 2008 Yearbook of Intensive Care and Emergency Medicine, Springer-Verlag, Berlin.
- Nguyen YLC, Mayr FB, Angus DC. Intensive care use and end-of-life decision-making -An American and European perspective. In: Vincent J-L (ed), 2010 Yearbook of Intensive Care and Emergency Medicine, Springer-Verlag, Berlin.
|